Health Care Deal News, February 11, 2013 - Inspiration Biopharmaceuticals Inc. is in Bankruptcy Proceedings, Spotlight On: Biotechnology

 

Brought to you by www.DealSearchOnline.com
 

February 11, 2013 Issue:

 

  1. Recent Health Care M&A Deals 
  2. Spotlight On: Biotechnology
  3. Spotlight on: E-Health
  4. Webcast Calendar

Recent Health Care M&A Deals

BIOTECHNOLOGY

Acquirer

Target

Price

Biogen Idec, Inc.

TYSABRI

$3.25 billion

Cangene  Corporation

Rights to IB1001

$55.9 million

 Aduro BioTech, Inc.

 GVAX Assets

 $1 million

PHARMACEUTICALS

Acquirer

Target

Price

Isotechnika Pharma Inc.

Aurinia Pharmaceuticals

$3.86 million

OTHER

Acquirer

Target

Price

 Selway Capital Acquisition Corporation

 Healthcare Corporation of America

 $74.8 million

 

Upcoming Interactive M&A Webcast:
Senior Care Merger and Acquisition Review and Outlook for 2013
Thursday, February 28, 2013, 1:00 pm ET            
In 2012, values remained relatively high across the seniors housing and care spectrum: skilled nursing facilities, assisted and independent living communities, and memory care facilities. How long will this bull market last, and what could bring an end to it? Find out from our expert panel: Stephen M. Monroe (Moderator), Managing Editor and Partner, Irving Levin Associates, Inc.; Larry Cohen, CEO of Capital Senior Living; Mike Pardoll, Senior Vice President/Investments, Marcus & Millichap; and Laca Wong-Hammond, Head of Healthcare Real Estate, Healthcare Investment Banking, Raymond James Morgan Keegan.
Go to http://www.levinassociates.com/conferences/1302b-online-conference or call 800-248-1668 to register.

 

Spotlight on: Biotechnology
Inspiration Biopharmaceuticals Inc. is in bankruptcy proceedings, so it is selling its rights to hemophilia compound OBI-1 as well as related assets, to Baxter International, Inc. (NYSE: BAX). Paris-based Ipsen Pharma S.A.S. (Euronext: IPN; ADR; IPSEY) is selling other OBI-1 related assets, including manufacturing operations in Milford, Massachusetts, to Baxter.....Read more

 

NEW- The Health Care Services Acquisition Report, 19th Edition - Preorder Today!
Deals have been made. The 2013 Health Care Services Acquisition Report contains private deals in this market that are too small to make it into the financial press. Take advantage of our limited 2-for-1 offer - preorder The 2013 Health Care Services Acquisition Report by March 31st  and receive The 2012 Health Care Services Acquisition Report FREE ($595 value)! Now that’s a recession resistant deal. Go to http://www.levinassociates.com/hardescription or call 800-248-1668 to preorder today!

 

Spotlight on: E-Health
Epocrates Inc. (NASDAQ: EPOC), owner of the popular iPhone app voted “Most Important Mobile Health-Care App” last December by readers of ModernHealthcare.com, was acquired by athenahealth, Inc. (NASDAQ: ATHN) on January 7 for $293 million cash, equivalent to $11.25 per share, or a 22% premium.....Read more

 
Conference Calendar...Click here to see more